1-(3,4-二氯苯基)-3-苯基-1-丙酮 | 49747-54-8

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 直链 1,3-二芳基丙烷
• 中文名称: 1-(3,4-二氯苯基)-3-苯基-1-丙酮
• 英文名称: 1-(3',4'-dichlorophenyl)-3-phenyl propanone
• 英文别名: 1-(3',4'-dichlorophenyl)-3-phenyl-propanone；entspr. Chalcon I, Hydrierung；1-(3,4-Dichlorophenyl)-3-phenylpropan-1-one
• CAS: 49747-54-8
• 化学式: C₁₅H₁₂Cl₂O
• 分子量: 279.166
• InChiKey: DLECOFJLJXJDSS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  18
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.13
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  1-(3,4-二氯苯基)-3-苯基-1-丙酮 在 sodium tetrahydroborate 、 氯化亚砜 作用下， 生成 1-chloro-1-(3,4-dichloro-phenyl)-3-phenyl-propane
  参考文献：
  名称：

  Lal,B. et al., Indian Journal of Chemistry, 1973, vol. 11, p. 423 - 426

  摘要：

  DOI：
• 作为产物：
  描述：

  3,4-dichlorochalcone 在 palladium on activated charcoal 氢气 作用下， 生成 1-(3,4-二氯苯基)-3-苯基-1-丙酮
  参考文献：
  名称：

  Lal,B. et al., Indian Journal of Chemistry, 1973, vol. 11, p. 423 - 426

  摘要：

  DOI：

文献信息

• 4-phenyl-4-oxo-2-butenoic acid derivatives with kynurenine-3-hydroxylase
  申请人：Pharmacia & Upjohn S.p.A.

  公开号：US06048896A1

  公开（公告）日：2000-04-11

  4-Phenyl-4-oxo-butenoic acid derivatives for use in the treatment of the human or animal body by therapy; particularly as kynurenine-3-hydroxylase inhibitors, in the prevention and/or treatment of a neurodegenerative disease wherein the inhibition of such an enzyme is needed. The present invention further comprises a selected class of the above mentioned 4-phenyl-4-oxo-butenoic acid derivatives, their pharmaceutically acceptable salts, a process for their preparation and pharmaceutical compositions containing them.

  4-苯基-4-氧代-丁烯酸衍生物用于治疗人体或动物身体的疗法；特别是作为骈酮-3-羟化酶抑制剂，在需要抑制这种酶的神经退行性疾病的预防和/或治疗中。本发明还包括上述4-苯基-4-氧代-丁烯酸衍生物的选定类别，它们的药用盐，以及用于它们的制备的方法和含有它们的药物组合物。
• 4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity
  申请人：Pharmacia & Upjohn S.p.A.

  公开号：US06323240B1

  公开（公告）日：2001-11-27

  4-phenyl-4-oxo-butanoic acid derivatives for use in the treatment of the human or animal body by therepy; particularly as kynurenine-3-hydroxylase inhibitors, in the prevention and/or treatment of a neurodegenerative disease wherein the inhibition of such an enyzme is needed. The present invention further comprises a selected class of the above mentioned 4-phenyl-4-oxo-butanoic acid derivatives, their pharmaceutically acceptable salts, a process for their preparation and pharmaceutical compositions containing them.

  用于治疗人体或动物身体的4-苯基-4-氧代丁酸衍生物，特别是作为酪氨酸3-羟化酶抑制剂，在需要抑制此类酶的神经退行性疾病的预防和/或治疗中。本发明还包括上述4-苯基-4-氧代丁酸衍生物的选定类别，它们的药学上可接受的盐，以及用于其制备的过程和含有它们的药物组合物。
• [EN] 4-PHENYL-4-OXO-2-BUTENOIC ACID DERIVATIVES WITH KYNURENINE-3-HYDROXYLASE INHIBITING ACTIVITY<br/>[FR] DERIVES DE L'ACIDE 4-PHENYL-4-OXO-2-BUTENOIQUE POSSEDANT UNE ACTIVITE INHIBITRICE DE LA KYNURENINE-3-HYDROXYLASE
  申请人：PHARMACIA & UPJOHN S.P.A.

  公开号：WO1997017316A1

  公开（公告）日：1997-05-15

  (EN) 4-Phenyl-4-oxo-butenoic acid derivatives for use in the treatment of the human or animal body by therapy; particularly as kynurenine-3-hydroxylase inhibitors, in the prevention and/or treatment of a neurodegenerative disease wherein the inhibition of such an enzyme is needed. The present invention further comprises a selected class of the above mentioned 4-phenyl-4-oxo-butenoic acid derivatives, their pharmaceutically acceptable salts, a process for their preparation and pharmaceutical compositions containing them.(FR) On décrit des dérivés de l'acide 4-phényl-4-oxo-buténoïque utiles en thérapeutique dans le traitement du corps humain ou animal, et notamment en tant qu'inhibiteurs de la kynurénine-3-hydroxylase dans la prévention et/ou le traitement de maladies neurodégénératives dans lesquelles il est nécessaire d'inhiber une telle enzyme. La présente invention comprend en outre une classe sélectionnée de dérivés de l'acide 4-phényl-4-oxo-buténoïque ci-dessus mentionnés, leurs sels pharmaceutiquement acceptables, un procédé de préparation de ces dérivés, ainsi que des compositions pharmaceutiques contenant ceux-ci.

  用于治疗人类或动物的4-苯基-4-羰基丙二酸衍生物，特别是在预防和/或治疗需要抑制上述酶的神经退行性疾病中的应用；特别是作为抗类碱磷酸化酶作为一种抑制性抗类碱磷酸化酶。本发明的其他部分包括上述提到的4-苯基-4-羰基丙二酸衍生物中选择的一类，其药用上可接受的盐，这些衍生物的合成方法及其包含在药用 compositions 中。
• Discovery of potent thiosemicarbazone inhibitors of rhodesain and cruzain
  作者：Naoaki Fujii、Jeremy P. Mallari、Elizabeth J. Hansell、Z. Mackey、Patricia Doyle、Y.M. Zhou、Jiri Gut、Philip J. Rosenthal、James H. McKerrow、R. Kiplin Guy

  DOI：10.1016/j.bmcl.2004.10.023

  日期：2005.1

  Herein we report the synthesis and evaluation of a series of thiosemicarbazones as potential inhibitors of cysteine proteases relevant to parasitic diseases. Derivatives of thiosemicarbazone 1 were discovered to be potent inhibitors of cruzain and rhodesain, crucial proteases in the life cycles of Trypanosoma cruzi and T. brucei rhodesiense, the organisms causing Chagas' disease and sleeping sickness. However, the entire series had only modest potency against falcipain-2, an essential protease for Plasmodium falciparum, the organism causing malaria. Among the active inhibitors, several potently inhibited proliferation of cultures of T. brucei. However, only modest activity was observed in inhibition of proliferation of T. cruzi or P. falciparum. (C) 2004 Elsevier Ltd. All rights reserved.
• 4-PHENYL-4-OXO-2-BUTENOIC ACID DERIVATIVES WITH KYNURENINE-3-HYDROXYLASE INHIBITING ACTIVITY
  申请人：PHARMACIA & UPJOHN S.p.A.

  公开号：EP0858442A1

  公开（公告）日：1998-08-19